7-103989356-TGCCGCCGCCGCCGCC-TGCCGCCGCCGCC
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_005045.4(RELN):c.-3_-1delGGC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00167 in 1,396,900 control chromosomes in the GnomAD database, including 35 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0016 ( 1 hom., cov: 0)
Exomes 𝑓: 0.0017 ( 34 hom. )
Consequence
RELN
NM_005045.4 5_prime_UTR
NM_005045.4 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.06
Genes affected
RELN (HGNC:9957): (reelin) This gene encodes a large secreted extracellular matrix protein thought to control cell-cell interactions critical for cell positioning and neuronal migration during brain development. This protein may be involved in schizophrenia, autism, bipolar disorder, major depression and in migration defects associated with temporal lobe epilepsy. Mutations of this gene are associated with autosomal recessive lissencephaly with cerebellar hypoplasia. Two transcript variants encoding distinct isoforms have been identified for this gene. Other transcript variants have been described but their full length nature has not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 7-103989356-TGCC-T is Benign according to our data. Variant chr7-103989356-TGCC-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 358429.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=2}. Variant chr7-103989356-TGCC-T is described in Lovd as [Likely_benign]. Variant chr7-103989356-TGCC-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00159 (236/148362) while in subpopulation EAS AF= 0.00404 (19/4698). AF 95% confidence interval is 0.00265. There are 1 homozygotes in gnomad4. There are 120 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 34 AD,AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00158 AC: 234AN: 148264Hom.: 1 Cov.: 0
GnomAD3 genomes
AF:
AC:
234
AN:
148264
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0113 AC: 720AN: 63892Hom.: 34 AF XY: 0.00989 AC XY: 366AN XY: 37010
GnomAD3 exomes
AF:
AC:
720
AN:
63892
Hom.:
AF XY:
AC XY:
366
AN XY:
37010
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00168 AC: 2097AN: 1248538Hom.: 34 AF XY: 0.00170 AC XY: 1043AN XY: 614850
GnomAD4 exome
AF:
AC:
2097
AN:
1248538
Hom.:
AF XY:
AC XY:
1043
AN XY:
614850
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00159 AC: 236AN: 148362Hom.: 1 Cov.: 0 AF XY: 0.00166 AC XY: 120AN XY: 72350
GnomAD4 genome
AF:
AC:
236
AN:
148362
Hom.:
Cov.:
0
AF XY:
AC XY:
120
AN XY:
72350
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2023 | RELN: BP4, BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Lissencephaly, Recessive Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at